Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off

Entacapone is frequently used together with levodopa/carbidopa (LC) and levodopa/benserazide (LB) in the treatment of Parkinson’s disease (PD) patients with wearing-off symptoms. It is generally assumed that the effects of entacapone are independent of the type of decarboxylase inhibitor used, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuoppamäki, Mikko, Leinonen, Mika, Poewe, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2015
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644189/
https://www.ncbi.nlm.nih.gov/pubmed/26347184
http://dx.doi.org/10.1007/s00702-015-1449-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644189/
https://www.ncbi.nlm.nih.gov/pubmed/26347184
http://dx.doi.org/10.1007/s00702-015-1449-6

Ejemplares similares